1. Home
  2. AIV vs ALT Comparison

AIV vs ALT Comparison

Compare AIV & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apartment Investment and Management Company

AIV

Apartment Investment and Management Company

HOLD

Current Price

$2.97

Market Cap

435.9M

Sector

Real Estate

ML Signal

HOLD

Logo Altimmune Inc.

ALT

Altimmune Inc.

HOLD

Current Price

$2.82

Market Cap

421.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIV
ALT
Founded
1975
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
435.9M
421.5M
IPO Year
1996
2005

Fundamental Metrics

Financial Performance
Metric
AIV
ALT
Price
$2.97
$2.82
Analyst Decision
Buy
Strong Buy
Analyst Count
1
6
Target Price
$10.00
$17.67
AVG Volume (30 Days)
1.7M
3.4M
Earning Date
05-06-2026
05-08-2026
Dividend Yield
87.41%
N/A
EPS Growth
616.00
25.37
EPS
N/A
N/A
Revenue
$138,486,000.00
$41,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
105.00
52 Week Low
$2.85
$2.56
52 Week High
$8.87
$6.44

Technical Indicators

Market Signals
Indicator
AIV
ALT
Relative Strength Index (RSI) 25.30 48.08
Support Level $2.85 $2.72
Resistance Level $4.30 $3.20
Average True Range (ATR) 0.06 0.12
MACD 0.02 0.03
Stochastic Oscillator 60.71 49.45

Price Performance

Historical Comparison
AIV
ALT

About AIV Apartment Investment and Management Company

Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment, and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development. Operating, and Other. The development segment consists of properties that are under construction or have not achieved stabilization, as well as land held for development. The operating segment includes residential apartments, communities with apartment homes that have achieved a stabilized level of operations. The other segment includes The Benson Hotel, the company's only hotel. The majority of revenue is gained from the Operating Segment.

About ALT Altimmune Inc.

Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: